These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 35081015)

  • 41. Mechanism of action of bimatoprost, latanoprost, and travoprost in healthy subjects. A crossover study.
    Lim KS; Nau CB; O'Byrne MM; Hodge DO; Toris CB; McLaren JW; Johnson DH
    Ophthalmology; 2008 May; 115(5):790-795.e4. PubMed ID: 18452763
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The effects of bimatoprost and unoprostone isopropyl on the intraocular pressure of normal cats.
    Bartoe JT; Davidson HJ; Horton MT; Jung Y; Brightman AH
    Vet Ophthalmol; 2005; 8(4):247-52. PubMed ID: 16008704
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Bimatoprost 0.01% vs bimatoprost 0.03%: a 12-month prospective trial of clinical and in vivo confocal microscopy in glaucoma patients.
    Figus M; Nardi M; Piaggi P; Sartini M; Guidi G; Martini L; Lazzeri S
    Eye (Lond); 2014 Apr; 28(4):422-9. PubMed ID: 24434659
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of bimatoprost on intraocular pressure in prostaglandin FP receptor knockout mice.
    Crowston JG; Lindsey JD; Morris CA; Wheeler L; Medeiros FA; Weinreb RN
    Invest Ophthalmol Vis Sci; 2005 Dec; 46(12):4571-7. PubMed ID: 16303950
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Topical Bimatoprost Insert for Primary Open-Angle Glaucoma and Ocular Hypertension Treatment - A Phase II Controlled Study.
    Rubião F; Araújo ACF; Sancio JB; Nogueira BS; Franca JR; Nogueira JC; Ferreira AJ; Faraco AAG; Foureaux G; Cronemberger S
    Curr Drug Deliv; 2021; 18(7):1022-1026. PubMed ID: 33388018
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dose-Response of Intracameral Bimatoprost Sustained-Release Implant and Topical Bimatoprost in Lowering Intraocular Pressure.
    Lee SS; Dibas M; Almazan A; Robinson MR
    J Ocul Pharmacol Ther; 2019 Apr; 35(3):138-144. PubMed ID: 30698494
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Bimatoprost 0.03% preservative-free ophthalmic solution versus bimatoprost 0.03% ophthalmic solution (Lumigan) for glaucoma or ocular hypertension: a 12-week, randomised, double-masked trial.
    Day DG; Walters TR; Schwartz GF; Mundorf TK; Liu C; Schiffman RM; Bejanian M
    Br J Ophthalmol; 2013 Aug; 97(8):989-93. PubMed ID: 23743437
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of travoprost, latanoprost and bimatoprost PGF2α treatments on the biomechanical properties of in-vivo rabbit cornea.
    Wang J; Zhao Y; Yu A; Wu J; Zhu M; Jiang M; Li X; Zhu D; Zhang P; Zheng X; Bao F; Elsheikh A
    Exp Eye Res; 2022 Feb; 215():108920. PubMed ID: 35007519
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evaluation of circadian control of intraocular pressure after a single drop of bimatoprost 0.03% or travoprost 0.004%.
    Frenkel RE; Noecker RJ; Craven ER
    Curr Med Res Opin; 2008 Apr; 24(4):919-23. PubMed ID: 18267054
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Human trabecular meshwork cell responses induced by bimatoprost, travoprost, unoprostone, and other FP prostaglandin receptor agonist analogues.
    Sharif NA; Kelly CR; Crider JY
    Invest Ophthalmol Vis Sci; 2003 Feb; 44(2):715-21. PubMed ID: 12556403
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Granulomatous anterior uveitis associated with bimatoprost: a case report.
    Parentin F
    Ocul Immunol Inflamm; 2003 Mar; 11(1):67-71. PubMed ID: 12854029
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Bimatoprost-loaded ocular inserts as sustained release drug delivery systems for glaucoma treatment: in vitro and in vivo evaluation.
    Franca JR; Foureaux G; Fuscaldi LL; Ribeiro TG; Rodrigues LB; Bravo R; Castilho RO; Yoshida MI; Cardoso VN; Fernandes SO; Cronemberger S; Ferreira AJ; Faraco AA
    PLoS One; 2014; 9(4):e95461. PubMed ID: 24788066
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Corneal alterations induced by topical application of commercial latanoprost, travoprost and bimatoprost in rabbit.
    Chen W; Dong N; Huang C; Zhang Z; Hu J; Xie H; Pan J; Liu Z
    PLoS One; 2014; 9(3):e89205. PubMed ID: 24632558
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of the effects of bimatoprost and a fixed combination of latanoprost and timolol on 24-hour blood and ocular perfusion pressures: the results of a randomized trial.
    Rossetti L; Sacchi M; Karabatsas CH; Topouzis F; Vetrugno M; Centofanti M; Boehm A; Vorwerk C; Goldblum D; Fogagnolo P
    BMC Ophthalmol; 2015 Jan; 15():7. PubMed ID: 25613811
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of efficacy of four prostaglandin analogues by bilateral treatment in healthy subjects.
    Kawaguchi I; Higashide T; Ohkubo S; Kawaguchi C; Sugiyama K
    Jpn J Ophthalmol; 2012 Jul; 56(4):346-53. PubMed ID: 22669351
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Hyperpigmentosis and hypertrichosis of the eyelids after use of bimatoprost eye drops].
    Modschiedler K; von den Driesch P; Paus R
    J Dtsch Dermatol Ges; 2005 Apr; 3(4):276-7. PubMed ID: 16370476
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of bimatoprost, latanoprost, and unoprostone on matrix metalloproteinases and their inhibitors in human ciliary body smooth muscle cells.
    Ooi YH; Oh DJ; Rhee DJ
    Invest Ophthalmol Vis Sci; 2009 Nov; 50(11):5259-65. PubMed ID: 19443729
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Comparison of intraocular pressure reducing effects of three prostaglandin eyedrops in open-angle glaucoma].
    Huang HL; Sun XH; Xiao M
    Zhonghua Yan Ke Za Zhi; 2011 Feb; 47(2):109-13. PubMed ID: 21426839
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Efficiency of instillation methods for prostaglandin medications.
    Fiscella R; Wilensky JT; Chiang TH; Walt JG
    J Ocul Pharmacol Ther; 2006 Dec; 22(6):477-82. PubMed ID: 17238816
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Adjunctive glaucoma therapy use associated with travoprost, bimatoprost, and latanoprost.
    Covert D; Robin AL
    Curr Med Res Opin; 2006 May; 22(5):971-6. PubMed ID: 16709319
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.